- Home
- BMRA vs NURO Comparison
BMRA vs NURO Comparison
Compare BMRA & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- NURO
- Stock Information
- Founded
- BMRA 1971
- NURO 1996
- Country
- BMRA United States
- NURO United States
- Employees
- BMRA N/A
- NURO N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NURO Medical/Dental Instruments
- Sector
- BMRA Health Care
- NURO Health Care
- Exchange
- BMRA Nasdaq
- NURO Nasdaq
- Market Cap
- BMRA 7.4M
- NURO 8.2M
- IPO Year
- BMRA N/A
- NURO N/A
- Fundamental
- Price
- BMRA $0.33
- NURO $4.55
- Analyst Decision
- BMRA
- NURO
- Analyst Count
- BMRA 0
- NURO 0
- Target Price
- BMRA N/A
- NURO N/A
- AVG Volume (30 Days)
- BMRA 68.2K
- NURO 15.0K
- Earning Date
- BMRA 10-15-2024
- NURO 11-01-2024
- Dividend Yield
- BMRA N/A
- NURO N/A
- EPS Growth
- BMRA N/A
- NURO N/A
- EPS
- BMRA N/A
- NURO N/A
- Revenue
- BMRA $5,509,000.00
- NURO $4,383,614.00
- Revenue This Year
- BMRA N/A
- NURO N/A
- Revenue Next Year
- BMRA N/A
- NURO N/A
- P/E Ratio
- BMRA N/A
- NURO N/A
- Revenue Growth
- BMRA 1.74
- NURO N/A
- 52 Week Low
- BMRA $0.24
- NURO $2.66
- 52 Week High
- BMRA $2.13
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- NURO 65.06
- Support Level
- BMRA $0.28
- NURO $3.96
- Resistance Level
- BMRA $0.35
- NURO $4.69
- Average True Range (ATR)
- BMRA 0.04
- NURO 0.22
- MACD
- BMRA 0.00
- NURO 0.04
- Stochastic Oscillator
- BMRA 41.67
- NURO 82.35
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.